Owen Mumford Confirms Recall Of Autopen And Densupen Insulin Pens Certain Batches ‘Could Pose Risk To Patients’ 18.12.2014 Medical device manufacturer has launched a recall of specific batches of its Autopen Classic, Autopen 24, Densupen and Autopen 3ml for Teriparatide insulin pens. The company has confirmed it is taking the step as a result of a potential mechanical fault in relation to the products, which would see a dose dialled up with the dose selector not holding the dose and spinning back to zero. In addition, the fault may also emerge when a dose is dialled up and the selector holds it momentarily, before then spinning back to zero. According to the company, this could lead to the patient not being able to use the pen as no dose may be delivered. Alternatively, the patient may receive a partial dose and will not know much insulin has been provided. Wholesalers, distributors and pharmacists have been asked to check batch numbers and place any affected under quarantine. A full list of the relevant batches is available on the Owen Mumford website. Tags Personal Injury Product Liability David Body Sheffield Related articles 25.05.2017Mum-of-Two Left Needing Emergency Surgery As Doctors Failed To Diagnose Sepsis 24.05.2017Lawyers Welcome 'Step Forward' In Wahaca Illness Legal Battle 23.05.2017Terminally Ill Hospital Worker Appeals To Former Colleagues After Asbestos Cancer Diagnosis 22.05.2017Former Commercial Manager Appeals To Former Colleagues For Help Following Cancer Diagnosis 22.05.2017Wallsend Road Bridge Asbestos Removal Welcomed 'But Questions Remain'